Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications
Therapeutic Advances in Pulmonary and Critical Care Medicine · 2024
DOI: 10.1177/29768675241300808 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Pulmonary and Critical Care Medicine, 2024. Verfasst von Mohammad Ajaz Alam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Avalon University School of Medicine, Willemstad, Curacao. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: COPD
Abstract (Originalsprache)
Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Syndrome (BCOS) is a complex pulmonary condition that merges bronchiectasis and chronic obstructive pulmonary disease (COPD), presenting unique clinical challenges. Patients with BCOS typically exhibit a range of symptoms from both conditions, including a chronic productive cough, reduced lung function, frequent exacerbations, and diminished exercise tolerance. The etiology of BCOS involves multiple factors such as genetic predisposition, respiratory infections, tobacco smoke, air pollutants, and other inflammatory mediators. Accurate diagnosis requires a comprehensive approach, incorporating pulmonary function tests to evaluate airflow limitation, radiographic imaging to identify structural lung abnormalities, and blood eosinophil counts to detect underlying inflammation. Treatment strategies are tailored to individual symptom profiles and severity, potentially including bronchodilators, inhaled corticosteroids, and pulmonary therapy to improve lung function and quality of life. Patients with BCOS are also at an increased risk for cardiovascular complications, such as stroke, ischemic heart disease, and cor pulmonale. Additionally, medications like beta-agonists and muscarinic antagonists used in COPD treatment can further affect cardiac risk by altering heart rate. This paper aims to provide a thorough understanding of BCOS, addressing its development, diagnosis, treatment, and associated cardiovascular complications, to aid healthcare providers in managing this multifaceted condition and improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Avalon University School of Medicine, Willemstad, Curacao.
- Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA.
- Dallastown Area High School, Dallastown, PA, USA.
- Department of Pulmonary Medicine, Fortis Escorts Heart Institute, Okhla, Delhi, India.
- Department of Internal Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
ORCID-Profile: Padmavathi Mangapuram, Fremita Chelsea Fredrick, Rohit Jain
Zitieren
APA
Alam, M. A., Mangapuram, P., Fredrick, F. C., Singh, B., Singla, A., Kumar, A., & Jain, R. (2024). Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications. Therapeutic Advances in Pulmonary and Critical Care Medicine. https://doi.org/10.1177/29768675241300808
Vancouver
Alam MA, Mangapuram P, Fredrick FC, Singh B, Singla A, Kumar A, et al. Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications. Therapeutic Advances in Pulmonary and Critical Care Medicine. 2024. doi:10.1177/29768675241300808
BibTeX
@article{Alam2024,
author = {Alam, Mohammad Ajaz and Mangapuram, Padmavathi and Fredrick, Fremita Chelsea and Singh, Bhupinder and Singla, Amishi and Kumar, Avi and Jain, Rohit},
title = {Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications},
journal = {Therapeutic Advances in Pulmonary and Critical Care Medicine},
year = {2024},
doi = {10.1177/29768675241300808}
}
EUVIMED